Adipose Inflammation and Diabetes (FAB)

Recruiting now

Conditions studied: Obese

In brief

The study investigates whether the addition of resolution molecules can inhibit inflammation and insulin resistance in human tissue taken from obese individuals, and whether the results of these studies correlate with patient-specific resolution phenotypes.

Key facts

Study ID

NCT04255264

Run by

Göteborg University

People needed

18

Starts

2019-08-01

Expected to finish

2027-06-30

Last updated by the study team

2025-05-06

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• BMI 30-40 kg/m2
• Ptos (i.e. excess skin) > 3 cm
• Patient underwent gastric bypass surgery >2 years ago
• Patient has had a stable weight ≥6 months at the time of operation
• Patient does not smoke (min 6 weeks prior to surgery)

You may not qualify if…

• Patients who do not understand spoken and written Swedish
• American Society of Anesthesiologists (ASA) classification ≥ 3
• Neurological, orthopedic or rheumatologic injury or illness affecting physical ability
• Preoperatively known hernia requiring surgical operation
• Severe mental illness

Where it is running

• Sahlgrenska university hospital — Gothenburg, Västra Götaland County, Sweden (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.